|
|
|
|
|
|
by zeristor
2052 days ago
|
|
|
Great story, it’s not quite there yet; finalisation of the testing, and mass production to be done. But with the huge financial and credibility boost I hope the team can follow their passion to solve other medical issues. Quite an insight to switch from cancer therapy to COVID-19 vaccine, and quite the opportunity to be able to deploy 500 researchers onto it at such an early stage. I hope this bolsters their original search for cancer treatment. |
|
|
Actually not at all. BioNTech's entire platform was customized RNA therapeutics that target the immune system to a particular patient's tumor. Basically cancer vaccines.